Literature DB >> 21846742

An SNP within the angiotensin-converting enzyme distinguishes between sprint and distance performing Alaskan sled dogs in a candidate gene analysis.

Heather J Huson1, Alexandra M Byers, Jonathan Runstadler, Elaine A Ostrander.   

Abstract

The Alaskan sled dog offers a unique mechanism for studying the genetics of elite athletic performance. They are a group of mixed breed dogs, comprised of multiple common breeds, and a unique breed entity seen only as a part of the sled dog mix. Alaskan sled dogs are divided into 2 primary groups as determined by their racing skills. Distance dogs are capable of running over 1000 miles in 10 days, whereas sprint dogs run much shorter distances, approximately 30 miles, but in faster times, that is, 18-25 mph. Finding the genes that distinguish these 2 types of performers is likely to illuminate genetic contributors to human athletic performance. In this study, we tested for association between polymorphisms in 2 candidate genes; angiotensin-converting enzyme (ACE) and myostatin (MSTN) and enhanced speed and endurance performance in 174 Alaskan sled dogs. We observed 81 novel genetic variants within the ACE gene and 4 within the MSTN gene, including a polymorphism within the ACE gene that significantly (P value 2.38 × 10(-5)) distinguished the sprint versus distance populations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21846742      PMCID: PMC3157885          DOI: 10.1093/jhered/esr022

Source DB:  PubMed          Journal:  J Hered        ISSN: 0022-1503            Impact factor:   2.645


  17 in total

1.  Myostatin mutation associated with gross muscle hypertrophy in a child.

Authors:  Markus Schuelke; Kathryn R Wagner; Leslie E Stolz; Christoph Hübner; Thomas Riebel; Wolfgang Kömen; Thomas Braun; James F Tobin; Se-Jin Lee
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

Review 2.  Angiotensin-converting enzyme and genetics at high altitude.

Authors:  D R Woods; H E Montgomery
Journal:  High Alt Med Biol       Date:  2001       Impact factor: 1.981

3.  A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep.

Authors:  Alex Clop; Fabienne Marcq; Haruko Takeda; Dimitri Pirottin; Xavier Tordoir; Bernard Bibé; Jacques Bouix; Florian Caiment; Jean-Michel Elsen; Francis Eychenne; Catherine Larzul; Elisabeth Laville; Françoise Meish; Dragan Milenkovic; James Tobin; Carole Charlier; Michel Georges
Journal:  Nat Genet       Date:  2006-06-04       Impact factor: 38.330

Review 4.  Genetics of athletic performance.

Authors:  Elaine A Ostrander; Heather J Huson; Gary K Ostrander
Journal:  Annu Rev Genomics Hum Genet       Date:  2009       Impact factor: 8.929

5.  Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training.

Authors:  H Montgomery; P Clarkson; M Barnard; J Bell; A Brynes; C Dollery; J Hajnal; H Hemingway; D Mercer; P Jarman; R Marshall; K Prasad; M Rayson; N Saeed; P Talmud; L Thomas; M Jubb; M World; S Humphries
Journal:  Lancet       Date:  1999-02-13       Impact factor: 79.321

6.  A genetic dissection of breed composition and performance enhancement in the Alaskan sled dog.

Authors:  Heather J Huson; Heidi G Parker; Jonathan Runstadler; Elaine A Ostrander
Journal:  BMC Genet       Date:  2010-07-22       Impact factor: 2.797

7.  Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle.

Authors:  Stefan Girgenrath; Kening Song; Lisa-Anne Whittemore
Journal:  Muscle Nerve       Date:  2005-01       Impact factor: 3.217

8.  Association between angiotensin-converting enzyme gene polymorphisms and exercise performance in patients with COPD.

Authors:  Xiaolei Zhang; Chen Wang; Huaping Dai; Yingxiang Lin; Jun Zhang
Journal:  Respirology       Date:  2008-09       Impact factor: 6.424

9.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Authors:  B Rigat; C Hubert; F Alhenc-Gelas; F Cambien; P Corvol; F Soubrier
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

10.  A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs.

Authors:  Dana S Mosher; Pascale Quignon; Carlos D Bustamante; Nathan B Sutter; Cathryn S Mellersh; Heidi G Parker; Elaine A Ostrander
Journal:  PLoS Genet       Date:  2007-04-30       Impact factor: 5.917

View more
  4 in total

Review 1.  Mechanisms governing the health and performance benefits of exercise.

Authors:  D Bishop-Bailey
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  Czechoslovakian Wolfdog Genomic Divergence from Its Ancestors Canis lupus, German Shepherd Dog, and Different Sheepdogs of European Origin.

Authors:  Nina Moravčíková; Radovan Kasarda; Radoslav Židek; Luboš Vostrý; Hana Vostrá-Vydrová; Jakub Vašek; Daniela Čílová
Journal:  Genes (Basel)       Date:  2021-05-28       Impact factor: 4.096

3.  Multi-species comparative analysis of the equine ACE gene identifies a highly conserved potential transcription factor binding site in intron 16.

Authors:  Natasha A Hamilton; Imke Tammen; Herman W Raadsma
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

4.  LDHA gene is associated with pigeon survivability during racing competitions.

Authors:  Sherif Ramadan; Takeshi Miyake; Junichi Yamaura; Miho Inoue-Murayama
Journal:  PLoS One       Date:  2018-05-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.